Literature DB >> 28159613

The vaccinia virus DNA polymerase and its processivity factor.

Maciej W Czarnecki1, Paula Traktman2.   

Abstract

Vaccinia virus is the prototypic poxvirus. The 192 kilobase double-stranded DNA viral genome encodes most if not all of the viral replication machinery. The vaccinia virus DNA polymerase is encoded by the E9L gene. Sequence analysis indicates that E9 is a member of the B family of replicative polymerases. The enzyme has both polymerase and 3'-5' exonuclease activities, both of which are essential to support viral replication. Genetic analysis of E9 has identified residues and motifs whose alteration can confer temperature-sensitivity, drug resistance (phosphonoacetic acid, aphidicolin, cytosine arabinsode, cidofovir) or altered fidelity. The polymerase is involved both in DNA replication and in recombination. Although inherently distributive, E9 gains processivity by interacting in a 1:1 stoichiometry with a heterodimer of the A20 and D4 proteins. A20 binds to both E9 and D4 and serves as a bridge within the holoenzyme. The A20/D4 heterodimer has been purified and can confer processivity on purified E9. The interaction of A20 with D4 is mediated by the N'-terminus of A20. The D4 protein is an enzymatically active uracil DNA glycosylase. The DNA-scanning activity of D4 is proposed to keep the holoenzyme tethered to the DNA template but allow polymerase translocation. The crystal structure of D4, alone and in complex with A201-50 and/or DNA has been solved. Screens for low molecular weight compounds that interrupt the A201-50/D4 interface have yielded hits that disrupt processive DNA synthesis in vitro and/or inhibit plaque formation. The observation that an active DNA repair enzyme is an integral part of the holoenzyme suggests that DNA replication and repair may be coupled.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA polymerase; DNA replication; Poxvirus; Processivity factor uracil DNA glycosylase; Vaccinia

Mesh:

Substances:

Year:  2017        PMID: 28159613      PMCID: PMC5476500          DOI: 10.1016/j.virusres.2017.01.027

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  89 in total

1.  The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase.

Authors:  N Klemperer; W McDonald; K Boyle; B Unger; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity.

Authors:  A Punjabi; K Boyle; J DeMasi; O Grubisha; B Unger; M Khanna; P Traktman
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants.

Authors:  K Ishii; B Moss
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition.

Authors:  J S Gibbs; H C Chiou; K F Bastow; Y C Cheng; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme.

Authors:  Kathleen A Boyle; Eleni S Stanitsa; Matthew D Greseth; Jill K Lindgren; Paula Traktman
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

6.  Herpes simplex virus type I DNA polymerase. Kinetic properties of the associated 3'-5' exonuclease activity and its role in araAMP incorporation.

Authors:  D Derse; Y C Cheng
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

7.  Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka; G Spizz
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

8.  The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.

Authors:  Don B Gammon; David H Evans
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

9.  Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.

Authors:  Don B Gammon; Robert Snoeck; Pierre Fiten; Marcela Krecmerová; Antonín Holý; Erik De Clercq; Ghislain Opdenakker; David H Evans; Graciela Andrei
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Functional consequences of the arabinosylcytosine structural lesion in DNA.

Authors:  T Mikita; G P Beardsley
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

View more
  20 in total

1.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Authors:  Tatiana G Senkevich; George C Katsafanas; Andrea Weisberg; Lisa R Olano; Bernard Moss
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.

Authors:  Peter J Kerr; John-Sebastian Eden; Francesca Di Giallonardo; David Peacock; June Liu; Tanja Strive; Andrew F Read; Edward C Holmes
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

4.  Host translesion polymerases are required for viral genome integrity.

Authors:  Sebastian Zeltzer; Pierce Longmire; Marek Svoboda; Giovanni Bosco; Felicia Goodrum
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-10       Impact factor: 12.779

5.  RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.

Authors:  Carey A Stuart; Erik K Zhivkoplias; Tatiana G Senkevich; Linda S Wyatt; Bernard Moss
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

6.  Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles.

Authors:  Baoming Liu; Debasis Panda; Jorge D Mendez-Rios; Sundar Ganesan; Linda S Wyatt; Bernard Moss
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 7.  The French Armed Forces Virology Unit: A Chronological Record of Ongoing Research on Orthopoxvirus.

Authors:  Déborah Delaune; Frédéric Iseni; Audrey Ferrier-Rembert; Christophe N Peyrefitte; Olivier Ferraris
Journal:  Viruses       Date:  2017-12-23       Impact factor: 5.048

8.  The vaccinia virus DNA polymerase structure provides insights into the mode of processivity factor binding.

Authors:  Nicolas Tarbouriech; Corinne Ducournau; Stephanie Hutin; Philippe J Mas; Petr Man; Eric Forest; Darren J Hart; Christophe N Peyrefitte; Wim P Burmeister; Frédéric Iseni
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

9.  Viral polymerases.

Authors:  Luis Menéndez-Arias; Raul Andino
Journal:  Virus Res       Date:  2017-02-08       Impact factor: 3.303

Review 10.  Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.

Authors:  Chad R Irwin; Mary M Hitt; David H Evans
Journal:  Front Oncol       Date:  2017-09-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.